Cargando…

The impact of mass drug administration expansion to low onchocerciasis prevalence settings in case of connected villages

BACKGROUND: The existence of locations with low but stable onchocerciasis prevalence is not well understood. An often suggested yet poorly investigated explanation is that the infection spills over from neighbouring locations with higher infection densities. METHODOLOGY: We adapted the stochastic in...

Descripción completa

Detalles Bibliográficos
Autores principales:	de Vos, Anneke S., Stolk, Wilma A., Coffeng, Luc E., de Vlas, Sake J.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2021
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8143415/ https://www.ncbi.nlm.nih.gov/pubmed/33979331 http://dx.doi.org/10.1371/journal.pntd.0009011

Ejemplares similares

The effect of assortative mixing on stability of low helminth transmission levels and on the impact of mass drug administration: Model explorations for onchocerciasis
por: de Vos, Anneke S., et al.
Publicado: (2018)

Required duration of mass ivermectin treatment for onchocerciasis elimination in Africa: a comparative modelling analysis
por: Stolk, Wilma A., et al.
Publicado: (2015)

Elimination of African Onchocerciasis: Modeling the Impact of Increasing the Frequency of Ivermectin Mass Treatment
por: Coffeng, Luc E., et al.
Publicado: (2014)

Predictive Value of Ov16 Antibody Prevalence in Different Subpopulations for Elimination of African Onchocerciasis
por: Coffeng, Luc E, et al.
Publicado: (2019)

How does onchocerciasis-related skin and eye disease in Africa depend on cumulative exposure to infection and mass treatment?
por: Vinkeles Melchers, Natalie V. S., et al.
Publicado: (2021)

Modelling Anti-Ov16 IgG4 Antibody Prevalence as an Indicator for Evaluation and Decision Making in Onchocerciasis Elimination Programmes
por: Lont, Yvonne L., et al.
Publicado: (2017)

The burden of skin disease and eye disease due to onchocerciasis in countries formerly under the African Programme for Onchocerciasis Control mandate for 1990, 2020, and 2030
por: Vinkeles Melchers, Natalie V. S., et al.
Publicado: (2021)

African Program for Onchocerciasis Control 1995–2010: Impact of Annual Ivermectin Mass Treatment on Off-Target Infectious Diseases
por: Krotneva, Stanimira P., et al.
Publicado: (2015)

Structural Uncertainty in Onchocerciasis Transmission Models Influences the Estimation of Elimination Thresholds and Selection of Age Groups for Seromonitoring
por: Hamley, Jonathan I D, et al.
Publicado: (2020)

Burden of onchocerciasis-associated epilepsy: first estimates and research priorities
por: Vinkeles Melchers, Natalie V. S., et al.
Publicado: (2018)

Standardisation of lymphatic filariasis microfilaraemia prevalence estimates based on different diagnostic methods: a systematic review and meta-analysis
por: Vinkeles Melchers, Natalie V. S., et al.
Publicado: (2020)

Onchocerciasis: The Pre-control Association between Prevalence of Palpable Nodules and Skin Microfilariae
por: Coffeng, Luc E., et al.
Publicado: (2013)

Scaling-Down Mass Ivermectin Treatment for Onchocerciasis Elimination: Modeling the Impact of the Geographical Unit for Decision Making
por: Stolk, Wilma A, et al.
Publicado: (2021)

African Programme for Onchocerciasis Control 1995–2015: Model-Estimated Health Impact and Cost
por: Coffeng, Luc E., et al.
Publicado: (2013)

Progress towards onchocerciasis elimination in the participating countries of the African Programme for Onchocerciasis Control: epidemiological evaluation results
por: Tekle, Afework H., et al.
Publicado: (2016)

African Programme for Onchocerciasis Control 1995–2015: Updated Health Impact Estimates Based on New Disability Weights
por: Coffeng, Luc E., et al.
Publicado: (2014)

Modeling the Impact and Costs of Semiannual Mass Drug Administration for Accelerated Elimination of Lymphatic Filariasis
por: Stolk, Wilma A., et al.
Publicado: (2013)

What does the COVID-19 pandemic mean for the next decade of onchocerciasis control and elimination?
por: Hamley, Jonathan I D, et al.
Publicado: (2021)

Achieving herd immunity against COVID-19 at the country level by the exit strategy of a phased lift of control
por: de Vlas, Sake J., et al.
Publicado: (2021)

Onchocerciasis: Target product profiles of in vitro diagnostics to support onchocerciasis elimination mapping and mass drug administration stopping decisions
por: Biamonte, Marco A., et al.
Publicado: (2022)

Correction: Onchocerciasis: Target product profiles of in vitro diagnostics to support onchocerciasis elimination mapping and mass drug administration stopping decisions
por: Biamonte, Marco A., et al.
Publicado: (2023)

Comparison and validation of two mathematical models for the impact of mass drug administration on Ascaris lumbricoides and hookworm infection
por: Coffeng, Luc E., et al.
Publicado: (2017)

Projected Number of People With Onchocerciasis–Loiasis Coinfection in Africa, 1995 to 2025
por: Vinkeles Melchers, Natalie V S, et al.
Publicado: (2020)

Onchocerciasis-associated epilepsy in Maridi, South Sudan: Modelling and exploring the impact of control measures against river blindness
por: Bhattacharyya, Samit, et al.
Publicado: (2023)

Antibody and Antigen Prevalence as Indicators of Ongoing Transmission or Elimination of Visceral Leishmaniasis: A Modeling Study
por: Coffeng, Luc E, et al.
Publicado: (2021)

Advances and challenges in predicting the impact of lymphatic filariasis elimination programmes by mathematical modelling
por: Stolk, Wilma A, et al.
Publicado: (2006)

How Can Onchocerciasis Elimination in Africa Be Accelerated? Modeling the Impact of Increased Ivermectin Treatment Frequency and Complementary Vector Control
por: Verver, Suzanne, et al.
Publicado: (2018)

Feasibility of Onchocerciasis Elimination Using a “Test-and-not-treat” Strategy in Loa loa Co-endemic Areas
por: Blok, David J, et al.
Publicado: (2020)

Feasibility of controlling hookworm infection through preventive chemotherapy: a simulation study using the individual-based WORMSIM modelling framework
por: Coffeng, Luc E., et al.
Publicado: (2015)

Two-stage lot quality assurance sampling framework for monitoring and evaluation of neglected tropical diseases, allowing for imperfect diagnostics and spatial heterogeneity
por: Kazienga, Adama, et al.
Publicado: (2022)

Appropriateness of the current parasitological control target for hookworm morbidity: A statistical analysis of individual-level data
por: Malizia, Veronica, et al.
Publicado: (2022)

Epidemiology of epilepsy and relationship with onchocerciasis prevalence in villages of the Ntui Health District of Cameroon
por: Ngarka, Leonard, et al.
Publicado: (2023)

Establishing a standard method for analysing case detection delay in leprosy using a Bayesian modelling approach
por: Hambridge, Thomas, et al.
Publicado: (2023)

The Power of Malaria Vaccine Trials Using Controlled Human Malaria Infection
por: Coffeng, Luc E., et al.
Publicado: (2017)

Modelling the impact of COVID-19-related programme interruptions on visceral leishmaniasis in India
por: Le Rutte, Epke A, et al.
Publicado: (2021)

The impact of ivermectin on onchocerciasis in villages co-endemic for lymphatic filariasis in an area of onchocerciasis recrudescence in Burkina Faso
por: Nikièma, Achille S., et al.
Publicado: (2021)

Modelling the health and economic impacts of the elimination of river blindness (onchocerciasis) in Africa
por: Kim, Young Eun, et al.
Publicado: (2017)

A general framework to support cost-efficient survey design choices for the control of soil-transmitted helminths when deploying Kato-Katz thick smear
por: Kazienga, Adama, et al.
Publicado: (2023)

Uncertainty quantification and sensitivity analysis of COVID-19 exit strategies in an individual-based transmission model
por: Gugole, Federica, et al.
Publicado: (2021)

Reducing societal impacts of SARS-CoV-2 interventions through subnational implementation
por: Dekker, Mark M, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_hc7920at2q8d0uej7kgqi0c8jd